Your browser doesn't support javascript.
loading
Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study.
Beri, Nina; Patrick-Miller, Linda J; Egleston, Brian L; Hall, Michael J; Domchek, Susan M; Daly, Mary B; Ganschow, Pamela; Grana, Generosa; Olopade, Olufunmilayo I; Fetzer, Dominique; Brandt, Amanda; Chambers, Rachelle; Clark, Dana F; Forman, Andrea; Gaber, Rikki; Gulden, Cassandra; Horte, Janice; Long, Jessica; Lucas, Terra; Madaan, Shreshtha; Mattie, Kristin; McKenna, Danielle; Montgomery, Susan; Nielsen, Sarah; Powers, Jacquelyn; Rainey, Kim; Rybak, Christina; Savage, Michelle; Seelaus, Christina; Stoll, Jessica; Stopfer, Jill E; Yao, Xinxin Shirley; Bradbury, Angela R.
Afiliación
  • Beri N; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Patrick-Miller LJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Egleston BL; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.
  • Hall MJ; Fox Chase Cancer Center, Temple University Health System, Biostatistics and Bioinformatics Facility, Philadelphia, Pennsylvania.
  • Domchek SM; Fox Chase Cancer Center, Temple University Health System, Department of Medical Genetics, Philadelphia, Pennsylvania.
  • Daly MB; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Ganschow P; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Grana G; Fox Chase Cancer Center, Temple University Health System, Department of Medical Genetics, Philadelphia, Pennsylvania.
  • Olopade OI; Department of Internal Medicine, The John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois.
  • Fetzer D; Division of Hematology-Oncology, MD Anderson Cancer Center at Cooper, Camden, New Jersey.
  • Brandt A; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.
  • Chambers R; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Clark DF; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Forman A; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Gaber R; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Gulden C; Division of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Horte J; Division of Hematology-Oncology, MD Anderson Cancer Center at Cooper, Camden, New Jersey.
  • Long J; Fox Chase Cancer Center, Temple University Health System, Department of Medical Genetics, Philadelphia, Pennsylvania.
  • Lucas T; Department of Internal Medicine, The John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois.
  • Madaan S; Division of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Mattie K; Division of Hematology-Oncology, MD Anderson Cancer Center at Cooper, Camden, New Jersey.
  • McKenna D; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Montgomery S; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Nielsen S; Department of Internal Medicine, The John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois.
  • Powers J; Division of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Rainey K; Division of Hematology-Oncology, MD Anderson Cancer Center at Cooper, Camden, New Jersey.
  • Rybak C; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Savage M; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Seelaus C; Fox Chase Cancer Center, Temple University Health System, Department of Medical Genetics, Philadelphia, Pennsylvania.
  • Stoll J; Division of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Stopfer JE; Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Yao XS; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Bradbury AR; Fox Chase Cancer Center, Temple University Health System, Department of Medical Genetics, Philadelphia, Pennsylvania.
Clin Genet ; 95(2): 293-301, 2019 02.
Article en En | MEDLINE | ID: mdl-30417332
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Revelación de la Verdad / Síndromes Neoplásicos Hereditarios / Comunicación / Prioridad del Paciente / Síndrome de Cáncer de Mama y Ovario Hereditario Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Genet Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Revelación de la Verdad / Síndromes Neoplásicos Hereditarios / Comunicación / Prioridad del Paciente / Síndrome de Cáncer de Mama y Ovario Hereditario Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Genet Año: 2019 Tipo del documento: Article